Forsta AP Fonden cut its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR – Free Report) by 15.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 230,700 shares of the real estate investment trust’s stock after selling 43,000 shares during the period. Forsta AP Fonden owned approximately 0.06% of Healthcare Realty Trust worth $4,459,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in HR. Belpointe Asset Management LLC acquired a new position in Healthcare Realty Trust in the fourth quarter valued at about $32,000. Ronald Blue Trust Inc. grew its stake in Healthcare Realty Trust by 105.5% in the fourth quarter. Ronald Blue Trust Inc. now owns 1,802 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 925 shares during the period. Harbour Investments Inc. acquired a new position in Healthcare Realty Trust in the fourth quarter valued at about $39,000. Signaturefd LLC grew its stake in Healthcare Realty Trust by 199.1% in the fourth quarter. Signaturefd LLC now owns 2,237 shares of the real estate investment trust’s stock valued at $43,000 after acquiring an additional 1,489 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its stake in Healthcare Realty Trust by 370.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,424 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,909 shares during the period. 98.54% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the company. Barclays boosted their target price on Healthcare Realty Trust from $24.00 to $25.00 in a research note on Thursday, May 11th. Wells Fargo & Company initiated coverage on Healthcare Realty Trust in a report on Wednesday, April 19th. They issued an “equal weight” rating on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.80.
Healthcare Realty Trust Price Performance
Healthcare Realty Trust Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, June 2nd. Investors of record on Tuesday, May 16th were issued a dividend of $0.31 per share. The ex-dividend date of this dividend was Monday, May 15th. This represents a $1.24 annualized dividend and a yield of 6.63%. Healthcare Realty Trust’s payout ratio is presently -620.00%.
About Healthcare Realty Trust
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March 31, 2023, the Company was invested in over 700 real estate properties totaling more than 40 million square feet and provided leasing and property management services to over 35 million square feet nationwide.
Read More
- Five stocks we like better than Healthcare Realty Trust
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
- 3 Large Semiconductor Makers Offering Dividends & Price Growth
Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HR – Free Report).
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.